Holen Sie sich die Stockscreener-App
72.29
0.01%
0.01
Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
12.04%
266.04
|
237.46 | 247.06 | 227.81 | 211.37 |
Selling, General, and Administrative
|
24.45%
91.66
|
73.66 | - | - | - |
| Costs And Expenses |
13.60%
225.58
|
198.57 | 212.29 | 191.57 | 197.48 |
| Depreciation and Amortization |
6.11%
19.64
|
20.92 | 22.61 | 22.63 | 23.28 |
| Operating Income/Loss |
4.04%
40.46
|
38.89 | 34.77 | 36.24 | 13.89 |
| Interest And Devidend Income |
2.09%
3.862
|
3.783 | 3.544 | 3.552 | 2.784 |
| Income/Loss From Continuing Operations Before Tax |
7.77%
37.10
|
40.22 | 31.48 | 33.80 | 10.53 |
| Income Tax Expense/Benefit |
15.44%
12.39
|
10.73 | 3.989 | 7.183 | 1.976 |
|
Net Income/Loss
|
16.21%
24.71
|
29.49 | 27.49 | 26.62 | 8.549 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | 0.344 | 0.407 |
| Basic Average Shares |
1.17%
21.16
|
20.91 | 0.213 | 20.07 | 19.83 |
| Diluted Average Shares |
1.72%
21.91
|
21.54 | 0.317 | 21.09 | 20.31 |
| Basic Earnings Per Share |
16.79%
1.09
|
1.31 | 1.24 | 1.19 | 0.37 |
| Diluted Earnings Per Share |
17.97%
1.05
|
1.28 | 1.17 | 1.13 | 0.36 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
17.06%
1.711
|
2.063 | 2.103 | 2.483 | 0.819 |
2.21%
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):